BERKELEY, Calif., June 8 /PRNewswire/ -- Aerovance Inc.

BERKELEY, Calif., Nov. 3 /PRNewswire/ -- Aerovance Inc. today announced it has completed patient enrollment in a Phase 2b clinical trial of the inhaled dry powder formulation of Aerovant for the treatment of uncontrolled asthma.

BERKELEY, Calif., April 7 /PRNewswire/ -- Aerovance Inc. today announced that it has secured $38 million in additional equity financing.

BERKELEY, Calif., March 2 /PRNewswire/ -- Aerovance Inc. today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) and the U.K.

BERKELEY, Calif., Feb. 9 /PRNewswire/ -- Aerovance Inc. today announced the appointment of Babatunde A. Otulana, M.D., to the position of senior vice president and chief medical officer. Dr.